Delivery Order SPE2DB22D3004-SPE2DB24FPR38
Award Date 3/13/24
Potential Completion Date 3/14/24
Potential Value $27K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $2,034.73 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide 4,563,802,239 units of the medication Meloxicam 15 mg Tablet 90s. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,757.33 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Meloxicam 15 mg. The contract was competitively awarded without set-aside designation under a firm fixed-price delivery order structure, with an ultimate completion date of May 7, 2025. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 15 mg meloxicam tablets. The order, valued at $7,916.30, is part of an Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which has a maximum value of $999,999,999 through December 2025. The contract is for the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs and...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Meloxicam 15 mg tablets in unit dose packaging (100 count) with a contract value of $7,948.48. The order, designated as a firm fixed price delivery order with an ultimate completion date of August 13, 2025, was competitively awarded without set-aside provisions. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,859.42 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Meloxicam 15 mg. This firm fixed-price, non-competitive set-aside contract was executed on September 16, 2025, with an ultimate completion date of September 17, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in that same city....
- The Defense Logistics Agency awarded a delivery order valued at $1,117.29 to AmerisourceBergen Drug Corp for the supply of Meloxicam 15 mg tablets in unit dose packaging (100s). This competitively awarded, firm fixed-price delivery order was issued on July 24, 2025, with an ultimate completion date of July 25, 2025. The contract specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania facility, which serves as the company's corporate headquarters and a critical distribution hub...
- This is a $1,223.76 firm fixed-price delivery order contract awarded by the Defense Logistics Agency to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Meloxicam 15 mg tablet units, a medication commonly used to treat pain and inflammation. The contract has a period of performance through June 4, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Meloxicam 15 mg tablet units (100 count) valued at $1,149.80 on September 15, 2025, with an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Meloxicam is a nonsteroidal anti-inflammatory drug commonly used in military and...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Meloxicam 15 mg tablets in unit dose packaging (100 count), with a ceiling value of $1,838.08 and a firm fixed price structure. This delivery order was issued without a set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the place of performance and serves as the...
- This federal contract award, identified as SPE2DX15D3005|SPE2DX25F3MQX, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp. The contract, valued at $17,697.34, is for the delivery of 4,566,307,554 units of Meloxicam 15 mg tablets. It is a firm fixed-price delivery order contract with a period of performance through November 4, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...